Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Kit
Product Images NDC 68462-849

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate (NDC 68462-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blisterimage (Blisterimage)

This appears to be a set of instructions for taking birth control pills. It includes specific instructions for people whose period starts on a day other than Sunday, and provides a label strip for them to use. There is a chart that outlines the weeks and corresponding pill packets, and there is information about the specific medication being taken, which includes Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules. Finally, there are directions indicating that the pills should be taken from left to right each week.*

FDA Label Image

Carton (Carton)

This text describes a medication package containing soft gelatin capsules for oral contraceptive use. The medication is a combination of norethindrone acetate, ethinyl estradiol, and ferrous fumarate. The package contains a blister with 24 opaque pale pink capsules and 4 maroon capsules. Each pale pink capsule contains 1mg of norethindrone acetate and 20mcg of ethinyl estradiol, while each maroon capsule contains 75mg of ferrous fumarate. The recommended dosage is one capsule daily. The package also includes information about storage, dosage, warnings, and contact information for the manufacturer.*

FDA Label Image

Ethinylestradiol (Ethinylestradiol)

FDA Label Image

Figure1 (Figure1)

This text provides a list of relevant studies that evaluated the risks of breast cancer associated with the use of combined oral contraceptives. The studies include MICHD Women's Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses’ Health Study 11, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The text also includes effect estimates in the form of OR, RR, and HR obtained from the studies.*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

This text appears to be a chart with three columns of numbers labeled "Day 1," "Day 24," and "Time (hours)" respectively. The first two columns have numbers ranging from 60 to 36, and there is a string of characters that is likely a username or a label in the middle. Without further context, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

Flowchart (Flowchart)

The given text provides information about the different methods and effectiveness of birth control. It showcases the number of pregnancies per 100 women in one year with and without birth control measures. The text further lists the various birth control methods such as implants, injections, pills, condoms, withdrawal, and more. It can be used as a quick reference guide for individuals seeking information on birth control.*

FDA Label Image

Glenmarklogo (Glenmarklogo)

FDA Label Image

Logo (Logo)

FDA Label Image

Norethindroneacetate (Norethindroneacetate)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.